Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: A report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Blood

Volumn 118, Issue 5, 2011, Pages 1413-1420

  Armenian, Saro H ^a   Sun, Can Lan ^a   Kawashima, Toana ^b   Arora, Mukta ^c   Leisenring, Wendy ^b   Sklar, Charles A ^d   Baker, K Scott ^b   Francisco, Liton ^a   Teh, Jennifer Berano ^a   Mills, George ^a   Wong, F Lennie ^a   Rosenthal, Joseph ^e   Diller, Lisa R ^f   Hudson, Melissa M ^g   Oeffinger, Kevin C ^d   Forman, Stephen J ^a   Robison, Leslie L ^g   Bhatia, Smita ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e CHILDREN S HOSPITAL CENTRAL CALIFORNIA   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; EPIPODOPHYLLOTOXIN DERIVATIVE; PLATINUM DERIVATIVE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DONOR; FEMALE; FUNCTIONAL DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK POPULATION; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PHYSICAL ACTIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SELF REPORT; SIBLING; TREATMENT OUTCOME;

EID: 79961085893     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-01-331835     Document Type: Article

References (45)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354(17):1813-1826.
2. Cairo MS, Heslop H. Pediatric blood and marrow transplantation: state of the science. Bone Marrow Transplant. 2008;41(2):97. (Pubitemid 351188905)
3. Cohen A, Bekassy AN, Gaiero A, et al. Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transplant. 2008;41(suppl 2):S43-S48. (Pubitemid 351864707)
4. Faraci M, Bekassy AN, De Fazio V, Tichelli A, Dini G. Nonendocrine late complications in children after allogeneic haematopoietic SCT. Bone Marrow Transplant. 2008;41(suppl 2):S49-S57. (Pubitemid 351864708)
5. Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23(27):6596-6606. (Pubitemid 46190253)
6. Ranke MB, Schwarze CP, Dopfer R, et al. Late effects after stem cell transplantation (SCT) in children-growth and hormones. Bone Marrow Transplant. 2005;35(Suppl 1):S77-S81. (Pubitemid 40613929)
7. Socié G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003;101(9):3373-3385. (Pubitemid 36857917)
8. Ferry C, Gemayel G, Rocha V, et al. Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant. 2007;40(3):219-224. (Pubitemid 47108464)
9. Uderzo C, Pillon M, Corti P, et al. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplant. 2007;39(11):667-675. (Pubitemid 46813583)
10. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572-1582. (Pubitemid 44547808)
11. Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003;290(12):1583-1592. (Pubitemid 37430383)
12. Castellino SM, Geiger AM, Mertens AC, et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. Oct 29 2010.
13. Mulrooney DA, Dover DC, Li S, et al. Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study. Cancer. 2008;112(9):2071-2079. (Pubitemid 351574084)
14. Robison LL, Armstrong GT, Boice JD, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol. 2009;27(14):2308-2318.
15. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multiinstitutional collaborative project. Med Pediatr Oncol. 2002;38(4):229-239. (Pubitemid 34258414)
16. Sun CL, Francisco L, Kawashima T, et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood. 2010;116(17):3129-3139.
17. Louie AD, Robison LL, Bogue M, Hyde S, Forman SJ, Bhatia S. Validation of self-reported complications by bone marrow transplantation survivors. Bone Marrow Transplant. 2000;25(11):1191-1196. (Pubitemid 30345255)
18. Fraser CJ, Bhatia S, Ness K, et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood. 2006;108(8):2867-2873.
19. Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort BMJ. 2009;339:b4606.
20. Green DM, Kawashima T, Stovall M, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009;27(16):2677-2685.
21. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004;22(24):4979-4990. (Pubitemid 46638624)
22. Rizzo JD, Wingard JR, Tichelli A, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2006;12(2):138-151. (Pubitemid 43138009)
23. Tichelli A, Rovo A, Passweg J, et al. Late complications after hematopoietic stem cell transplantation. Expert Rev Hematol. 2009;2(5):583-601.
24. Locatelli F, Labopin M, Ortega J, et al. Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission. Blood. 2003;101(4):1611-1619. (Pubitemid 36182542)
25. Bieri S, Roosnek E, Helg C, et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2008;42(12):819-827.
26. Andrykowski MA, Bishop MM, Hahn EA, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23(3):599-608. (Pubitemid 46224238)
27. Davies SM, Shu XO, Blazar BR, et al. Unrelated donor bone marrow transplantation: influence of HLAA and B incompatibility on outcome. Blood. 1995;86(4):1636-1642.
28. Lof CM, Forinder U, Winiarski J. Risk factors for lower health-related QoL after allogeneic stem cell transplantation in children. Pediatr Transplant. 2007;11(2):145-151. (Pubitemid 46174986)
29. Baker KS, Fraser CJ. Quality of life and recovery after graft-versus-host disease. Best Pract Res Clin Haematol. 2008;21(2):333-341. (Pubitemid 351720436)
30. Chemaitilly W, Sklar CA. Endocrine complications of hematopoietic stem cell transplantation. Endocrinol Metab Clin North Am. 2007;36(4):983-998; ix.
31. Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood. 2007;109(4):1765-1772. (Pubitemid 46239613)
32. Campbell S, Sun CL, Kurian S, et al. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer. 2009;115(18):4127-4135.
33. McAvoy S, Baker KS, Mulrooney D, et al. Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010;16(9):1231-1236.
34. Choi M, Sun CL, Kurian S, et al. Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation. Cancer. 2008;113(7):1580-1587.
35. Abboud I, Porcher R, Robin M, et al. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15(10):1251-1257.
36. Gurney JG, Ness KK, Rosenthal J, Forman SJ, Bhatia S, Baker KS. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study. Cancer. 2006;106(6):1402-1408. (Pubitemid 43363921)
37. Majhail NS, Ness KK, Burns LJ, et al. Late effects in survivors of Hodgkin and nonHodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant. 2007;13(10):1153-1159. (Pubitemid 47413009)
38. Armenian SH, Sun CL, Francisco L, et al. Late congestive heart failure after hematopoietic cell transplantation. J Clin Oncol. 2008;26(34):5537-5543.
39. Armenian SH, Sun CL, Mills G, et al. Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010;16(8):1138-1144.
40. Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 2008;111(12):5515-5523.
41. Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091-2101.
42. Baker KS, Bresters D, Sande JE. The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children. Pediatr Clin North Am. 2010;57(1):323-342.
43. ter Bals E, Kaspers GJ. Treatment of childhood acute myeloid leukemia. Expert Rev Anticancer Ther. 2005;5(5):917-929. (Pubitemid 41599965)
44. Hodgson DC, Hudson MM, Constine LS. Pediatric Hodgkin lymphoma: maximizing efficacy and minimizing toxicity. Semin Radiat Oncol. 2007;17(3):230-242. (Pubitemid 46970823)
45. Schrappe M, Beier R, Burger B. New treatment strategies in childhood acute lymphoblastic leukaemia. Best Pract Res Clin Haematol. 2002;15(4):729-740.